Related Experiment Video
Updated: Jul 22, 2025
Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR
Published on: January 22, 2014
Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer's disease
Ahmed Noor Eddin1, Khaled Hamsho1, Ghaith Adi1
1College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Abstract:
Alzheimer's disease (AD) is the leading form of dementia worldwide, but its early detection and diagnosis remain a challenge. MicroRNAs (miRNAs) are a group of small endogenous RNA molecules that regulate mRNA expression. Recent evidence suggests miRNAs play an important role in the five major hallmarks of AD pathophysiology: amyloidogenesis, tauopathy, neuroinflammation, synaptic dysfunction, and neuronal death. Compared to traditional biomarkers of AD, miRNAs display a greater degree of stability in cerebrospinal fluid. Moreover, aberrant changes in miRNA expression can be measured over time to monitor and guide patient treatment. Specific miRNA profiles and combinations may also be used to distinguish AD subjects from normal controls and other causes of dementia. Because of these properties, miRNAs are now being considered as promising and potential biomarkers of AD. This review comprehensively summarizes the diagnostic potential and regulatory roles miRNAs play in AD.
Insights
MicroRNAs show promise as Alzheimer's disease (AD) biomarkers. These small RNA molecules are stable in cerebrospinal fluid and can help detect AD and monitor treatment.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- Alzheimer's disease (AD) is a leading cause of dementia, with early diagnosis remaining a significant challenge.
- MicroRNAs (miRNAs) are small endogenous RNA molecules regulating gene expression, implicated in AD pathophysiology.
- miRNAs offer potential advantages over traditional biomarkers due to their stability in cerebrospinal fluid.
Purpose of the Study:
- To review the diagnostic potential of miRNAs in Alzheimer's disease.
- To summarize the regulatory roles of miRNAs in AD pathophysiology.
- To explore miRNAs as potential biomarkers for AD detection and monitoring.
Main Methods:
- Comprehensive literature review of studies on miRNAs in Alzheimer's disease.
- Analysis of miRNA expression patterns in relation to AD hallmarks.
- Evaluation of miRNA stability and detectability in cerebrospinal fluid.
Main Results:
- miRNAs are involved in key AD pathological processes including amyloidogenesis, tauopathy, neuroinflammation, synaptic dysfunction, and neuronal death.
- miRNA expression levels are altered in AD patients and can be detected in cerebrospinal fluid.
- Specific miRNA profiles may differentiate AD from other dementias and normal aging.
Conclusions:
- MicroRNAs represent promising biomarkers for early Alzheimer's disease detection and diagnosis.
- Monitoring miRNA expression can aid in tracking disease progression and guiding patient treatment.
- Further research into miRNA-based diagnostics holds significant potential for Alzheimer's disease management.
